Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China · Delayed Price · Currency is CNY 27.81
+0.31 (1.13%)
Jun 12, 2026, 3:04 PM CST
SHE:002940 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 127.19 | 125.44 | 80.33 | 138.37 | 127.3 | 119.84 |
Depreciation & Amortization | 76.78 | 76.78 | 87.58 | 78.78 | 61.1 | 46.36 |
Other Amortization | 2.04 | 2.04 | 1.76 | 1.71 | 0.67 | 0.77 |
Loss (Gain) From Sale of Assets | 0.03 | 0.03 | 0.01 | 0.04 | 0 | -0 |
Asset Writedown & Restructuring Costs | 1.34 | 1.34 | 2.92 | 1.96 | 5.94 | 3.5 |
Loss (Gain) From Sale of Investments | 17.18 | 17.18 | 5.15 | 0.32 | 1.86 | 8.38 |
Provision & Write-off of Bad Debts | -1.55 | -1.55 | -0.28 | -1.53 | - | - |
Other Operating Activities | -7.3 | 38.97 | 76.79 | 69.77 | 9.81 | 22.42 |
Change in Accounts Receivable | -27.17 | -27.17 | 11.35 | 86.63 | -47.82 | -39.99 |
Change in Inventory | 50.36 | 50.36 | -118.77 | -23.82 | 2.06 | -25.15 |
Change in Accounts Payable | -49.53 | -49.53 | 125.75 | -84.13 | 21.96 | 57.57 |
Change in Other Net Operating Assets | 0.93 | 0.93 | -0.06 | 9.34 | 2.11 | 1.8 |
Operating Cash Flow | 199.61 | 244.13 | 253.6 | 276.91 | 184.75 | 197.65 |
Operating Cash Flow Growth | 63.29% | -3.73% | -8.42% | 49.89% | -6.53% | -0.48% |
Capital Expenditures | -43.79 | -49.94 | -94.46 | -124.95 | -68.82 | -87.32 |
Sale of Property, Plant & Equipment | 0.17 | 0.22 | 1.87 | 0.5 | 0.21 | 0.38 |
Cash Acquisitions | - | - | - | -117.48 | - | 4.98 |
Investment in Securities | -164.62 | -38.55 | -372.68 | 67.91 | -453.36 | -151.4 |
Other Investing Activities | -19.21 | 2.3 | 3.36 | 4.02 | 0.65 | 0.56 |
Investing Cash Flow | -227.46 | -85.98 | -461.91 | -170.01 | -521.32 | -232.8 |
Long-Term Debt Issued | - | 195.31 | 457.57 | 545.95 | 372.89 | 2 |
Total Debt Issued | 277.55 | 195.31 | 457.57 | 545.95 | 372.89 | 2 |
Long-Term Debt Repaid | - | -227.92 | -559.87 | -383.72 | -27.99 | -12 |
Total Debt Repaid | -230.17 | -227.92 | -559.87 | -383.72 | -27.99 | -12 |
Net Debt Issued (Repaid) | 47.38 | -32.61 | -102.3 | 162.23 | 344.9 | -10 |
Issuance of Common Stock | - | - | - | - | 63.32 | - |
Repurchase of Common Stock | -9.61 | -9.61 | -54.38 | -20.12 | - | -63.34 |
Common Dividends Paid | -32.64 | -57.6 | -58.77 | -61.62 | -34.16 | -47.06 |
Other Financing Activities | -64.38 | -59.93 | -97.99 | -64.85 | 2.55 | -3.2 |
Financing Cash Flow | -59.25 | -159.75 | -313.44 | 15.65 | 376.62 | -123.6 |
Foreign Exchange Rate Adjustments | -1.9 | 0.35 | 7.21 | 1.16 | 1.27 | -0.58 |
Net Cash Flow | -88.99 | -1.24 | -514.53 | 123.72 | 41.32 | -159.33 |
Free Cash Flow | 155.83 | 194.19 | 159.14 | 151.96 | 115.92 | 110.33 |
Free Cash Flow Growth | 168.00% | 22.02% | 4.72% | 31.09% | 5.07% | 2.49% |
Free Cash Flow Margin | 10.98% | 13.63% | 10.35% | 9.38% | 7.39% | 7.99% |
Free Cash Flow Per Share | 0.80 | - | 0.79 | 0.76 | 0.58 | 0.55 |
Cash Interest Paid | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Cash Income Tax Paid | 60.18 | 76.83 | 34.88 | 45.91 | 64.32 | 141.61 |
Levered Free Cash Flow | 86.96 | 126.04 | 78.78 | -15.38 | 57.79 | 26.09 |
Unlevered Free Cash Flow | 94.87 | 134.17 | 89.15 | -6.52 | 61.78 | 26.32 |
Change in Working Capital | -16.09 | -16.09 | -0.69 | -12.5 | -21.93 | -3.62 |